500+ Gene Liquid Biopsy
February 28, 2017 | Terry Sharrer
Liquid biopsy isn’t yet the gold standard for tumor analysis, but it is moving rapidly in that direction. This piece describes Guardant’s (Redwood City, CA) 500+ gene panel (largest in the industry to date) that conceivably could test cancer patients for every targeted therapy that’s available or in clinical trials, while also monitoring responses to treatment. This product should be available for clinical use later this year. MORE
Image Credit: Wikimedia.commons